Market Overview:
The global computational medicine and drug discovery software market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for advanced software for drug discovery and development, rising prevalence of chronic diseases, and growing investments in R&D by pharmaceutical companies. Based on type, the global computational medicine and drug discovery software market is segmented into database, software, and others. The database segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 11% during the forecast period from 2018 to 2030. This growth can be attributed to the increasing demand for databases that store large amounts of data related to drugs and their targets. Based on application,the global computational medicine and drug discovery software market is divided into computations physiological medicine,drug discovery & development,, medical imaging,, disease modeling,, predictive analysisofdrug targets,, cellular simulation,.and simulationsoftware..
Product Definition:
Computational Medicine and Drug Discovery Software is used to help find new drugs and treatments. It uses computers to model diseases, test potential treatments, and predict how a drug will work in the body. This software is important because it can help speed up the process of finding new drugs and treatments.
Database:
The global database market size was valued at USD 1.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing demand for advanced data storage techniques is one of the key factors driving growth in this industry.
Software:
The global software and it's usage in computational medicine and drug discovery market was valued at USD 6.1 billion in 2015. The increasing demand for personalized healthcare, rising prevalence of chronic diseases, the need to reduce healthcare costs coupled with the technological advancements are some major factors driving growth over the forecast period.
Application Insights:
The computational physiological medicine segment dominated the global market in terms of revenue in 2017. Computational physiological modeling and simulation offer several advantages over traditional methods for drug discovery and development. The key advantages include enhanced predictive capabilities, improved ability to detect interactions between different drugs, reduced need for animal testing, reduced time required for analysis, cost-effectiveness and ease of use.
Drug discovery & development is expected to be the fastest growing application segment during the forecast period owing to increasing R&D investments by various companies such as Pfizer Inc., Merck KGaA., Novartis AG., sanofi aventis; GlaxoSmithKline Plc.; Astrazeneca Pharmaceuticals; Bayer HealthCare LLC.; Johnson & Johnson; etc. Furthermore, introduction of advanced software packages that enable fast screening of millions of compounds at once is also anticipated to contribute significantly towards growth during the same period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D and increasing adoption of advanced technologies across healthcare sectors. Moreover, growing focus on improving healthcare infrastructure is also expected to drive demand for CAM/CAD software over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising investments by governments and private firms for developing novel software applications based on computational methods within various biomedical fields such as drug discovery & development, medical imaging, disease modeling and predictive analysis of drug targets cellular simulation etc.
The Latin American market was estimated at USD X million in 2017.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Growing number of drug-resistant infections
- Advances in genomic sequencing and bioinformatics technologies
- Proliferation of big data in healthcare
Scope Of The Report
Report Attributes
Report Details
Report Title
Computational Medicine and Drug Discovery Software Market Research Report
By Type
Database, Software, Others
By Application
Computational Physiological Medicine, Drug Discovery And Development, Medical Imaging, Disease Modeling, Predictive Analysis Of Drug Targets, Cellular Simulation, Simulation Software
By Companies
Entelos, Genedata, Crown Bioscience, Biognos, Chemical Computing Group, Leadscope, Nimbus Therapeutics, Rhenovia Pharma Limited, Schrodinger, Compugen, Dassault Systemes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Computational Medicine and Drug Discovery Software Market Report Segments:
The global Computational Medicine and Drug Discovery Software market is segmented on the basis of:
Types
Database, Software, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Computational Physiological Medicine, Drug Discovery And Development, Medical Imaging, Disease Modeling, Predictive Analysis Of Drug Targets, Cellular Simulation, Simulation Software
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Entelos
- Genedata
- Crown Bioscience
- Biognos
- Chemical Computing Group
- Leadscope
- Nimbus Therapeutics
- Rhenovia Pharma Limited
- Schrodinger
- Compugen
- Dassault Systemes
Highlights of The Computational Medicine and Drug Discovery Software Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Database
- Software
- Others
- By Application:
- Computational Physiological Medicine
- Drug Discovery And Development
- Medical Imaging
- Disease Modeling
- Predictive Analysis Of Drug Targets
- Cellular Simulation
- Simulation Software
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Computational Medicine and Drug Discovery Software Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Computational medicine and drug discovery software is a type of software that helps researchers find new ways to treat diseases. This software can help scientists design better treatments for diseases by helping them understand how the body works.
Some of the major companies in the computational medicine and drug discovery software market are Entelos, Genedata, Crown Bioscience, Biognos, Chemical Computing Group, Leadscope, Nimbus Therapeutics, Rhenovia Pharma Limited, Schrodinger, Compugen, Dassault Systemes.
The computational medicine and drug discovery software market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Computational Medicine and Drug Discovery Software Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Computational Medicine and Drug Discovery Software Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Computational Medicine and Drug Discovery Software Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Computational Medicine and Drug Discovery Software Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Computational Medicine and Drug Discovery Software Market Size & Forecast, 2018-2028
4.5.1 Computational Medicine and Drug Discovery Software Market Size and Y-o-Y Growth
4.5.2 Computational Medicine and Drug Discovery Software Market Absolute $ Opportunity
Chapter 5 Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Computational Medicine and Drug Discovery Software Market Size Forecast by Type
5.2.1 Database
5.2.2 Software
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Computational Medicine and Drug Discovery Software Market Size Forecast by Applications
6.2.1 Computational Physiological Medicine
6.2.2 Drug Discovery And Development
6.2.3 Medical Imaging
6.2.4 Disease Modeling
6.2.5 Predictive Analysis Of Drug Targets
6.2.6 Cellular Simulation
6.2.7 Simulation Software
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Computational Medicine and Drug Discovery Software Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Computational Medicine and Drug Discovery Software Analysis and Forecast
9.1 Introduction
9.2 North America Computational Medicine and Drug Discovery Software Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Computational Medicine and Drug Discovery Software Market Size Forecast by Type
9.6.1 Database
9.6.2 Software
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Computational Medicine and Drug Discovery Software Market Size Forecast by Applications
9.10.1 Computational Physiological Medicine
9.10.2 Drug Discovery And Development
9.10.3 Medical Imaging
9.10.4 Disease Modeling
9.10.5 Predictive Analysis Of Drug Targets
9.10.6 Cellular Simulation
9.10.7 Simulation Software
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Computational Medicine and Drug Discovery Software Analysis and Forecast
10.1 Introduction
10.2 Europe Computational Medicine and Drug Discovery Software Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Computational Medicine and Drug Discovery Software Market Size Forecast by Type
10.6.1 Database
10.6.2 Software
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Computational Medicine and Drug Discovery Software Market Size Forecast by Applications
10.10.1 Computational Physiological Medicine
10.10.2 Drug Discovery And Development
10.10.3 Medical Imaging
10.10.4 Disease Modeling
10.10.5 Predictive Analysis Of Drug Targets
10.10.6 Cellular Simulation
10.10.7 Simulation Software
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Computational Medicine and Drug Discovery Software Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Computational Medicine and Drug Discovery Software Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Computational Medicine and Drug Discovery Software Market Size Forecast by Type
11.6.1 Database
11.6.2 Software
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Computational Medicine and Drug Discovery Software Market Size Forecast by Applications
11.10.1 Computational Physiological Medicine
11.10.2 Drug Discovery And Development
11.10.3 Medical Imaging
11.10.4 Disease Modeling
11.10.5 Predictive Analysis Of Drug Targets
11.10.6 Cellular Simulation
11.10.7 Simulation Software
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Computational Medicine and Drug Discovery Software Analysis and Forecast
12.1 Introduction
12.2 Latin America Computational Medicine and Drug Discovery Software Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Computational Medicine and Drug Discovery Software Market Size Forecast by Type
12.6.1 Database
12.6.2 Software
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Computational Medicine and Drug Discovery Software Market Size Forecast by Applications
12.10.1 Computational Physiological Medicine
12.10.2 Drug Discovery And Development
12.10.3 Medical Imaging
12.10.4 Disease Modeling
12.10.5 Predictive Analysis Of Drug Targets
12.10.6 Cellular Simulation
12.10.7 Simulation Software
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Computational Medicine and Drug Discovery Software Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Computational Medicine and Drug Discovery Software Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Computational Medicine and Drug Discovery Software Market Size Forecast by Type
13.6.1 Database
13.6.2 Software
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Computational Medicine and Drug Discovery Software Market Size Forecast by Applications
13.10.1 Computational Physiological Medicine
13.10.2 Drug Discovery And Development
13.10.3 Medical Imaging
13.10.4 Disease Modeling
13.10.5 Predictive Analysis Of Drug Targets
13.10.6 Cellular Simulation
13.10.7 Simulation Software
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Computational Medicine and Drug Discovery Software Market: Competitive Dashboard
14.2 Global Computational Medicine and Drug Discovery Software Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Entelos
14.3.2 Genedata
14.3.3 Crown Bioscience
14.3.4 Biognos
14.3.5 Chemical Computing Group
14.3.6 Leadscope
14.3.7 Nimbus Therapeutics
14.3.8 Rhenovia Pharma Limited
14.3.9 Schrodinger
14.3.10 Compugen
14.3.11 Dassault Systemes
